Clover Health Highlights Transparency With Supplemental Earnings Q&A
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Clover Health Investments ( (CLOV) ) just unveiled an update.
On March 6, 2026, Clover Health Investments, Corp. published written responses to a selection of frequently asked supplemental questions tied to its fourth-quarter 2025 earnings announcement, aiming to deepen engagement with its shareholder base. By releasing this additional Q&A through its investor relations website and a current report, the company is signaling an emphasis on transparency and ongoing investor communication, which may help clarify its performance narrative and strengthen relationships with existing and prospective shareholders.
The most recent analyst rating on (CLOV) stock is a Hold with a $2.75 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
The score is held back primarily by weak profitability and the 2025 reversal to negative operating/free cash flow, despite a strong net-debt-free balance sheet and solid recent revenue/membership growth. Technicals are also unfavorable with price below key moving averages and negative MACD, while valuation lacks support due to losses and no dividend. The earnings call provides a modest offset via growth and 2026 profitability aspirations, but near-term guidance cuts and medical cost pressure keep risk elevated.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health Investments, Corp. operates in the health care industry as a technology-driven health insurer, focusing on Medicare Advantage and related health plans for seniors and other eligible populations in the U.S. The company emphasizes data and software tools to manage member care and costs, and communicates regularly with public equity investors as part of its market-facing strategy.
Average Trading Volume: 5,508,998
Technical Sentiment Signal: Sell
Current Market Cap: $1.07B
See more insights into CLOV stock on TipRanks’ Stock Analysis page.
